UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I-II

International journal of oncology, 2016-03, Vol.48 (3), p.998-1006

2016

Volltextzugriff (PDF)

Prognostic Impact of p53, p27, and C-MYC on Clinicopathological Features and Outcome in Early-Stage (FIGO I-II) Epithelial Ovarian Cancer

International journal of gynecological cancer, 2011-02, Vol.21 (2), p.236-244

2011

Volltextzugriff (PDF)

Borderline ovarian tumors in Sweden 1960–2005: Trends in incidence and age at diagnosis compared to ovarian cancer

International journal of cancer, 2008-10, Vol.123 (8), p.1897-1901

2008

Volltextzugriff (PDF)

Prognostic Impact of Concomitant p53 and PTEN on Outcome in Early Stage (FIGO I-II) Epithelial Ovarian Cancer

International journal of gynecological cancer, 2011-08, Vol.21 (6), p.1024-1031

2011

Volltextzugriff (PDF)

Prognostic factors for surgical outcome and survival in 447 women treated for advanced (FIGO-stages III-IV) epithelial ovarian carcinoma

International journal of oncology, 2007-03, Vol.30 (3), p.727-734

2007

Volltextzugriff (PDF)

Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease

BMC cancer, 2012-09, Vol.12 (1), p.407-407, Article 407

2012

Volltextzugriff (PDF)

The clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancer

PloS one, 2017-06, Vol.12 (6), p.e0179363

2017

Volltextzugriff (PDF)

Prognostic Factors for Cervical Cancer in FIGO-Stages IA-IIB in a 10-Year Period in the Region of Uppsala, Sweden: Population Cohort Study

Annals of Clinical Oncology, 2022-10, p.1-8

2022

Volltextzugriff (PDF)

Clinical significance of growth factor receptor EGFR and angiogenesis regulator VEGF‑R2 in patients with ovarian cancer at FIGO stages I-II

International journal of oncology, 2018-10, Vol.53 (4), p.1633-1642

2018

Volltextzugriff (PDF)

Differences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma

International journal of gynecological cancer, 2015-09, Vol.25 (7), p.1239-1247

2015

Volltextzugriff (PDF)

Body mass index as a prognostic factor in epithelial ovarian cancer and correlation with clinico-pathological factors

Acta obstetricia et gynecologica Scandinavica, 2010-01, Vol.89 (1), p.101-107

2010

Volltextzugriff (PDF)

Association of p21, p21 p27 and p21 p53 status to histological subtypes and prognosis in low-stage epithelial ovarian cancer

Cancer genomics & proteomics, 2013-01, Vol.10 (1), p.27-34

2013

Volltextzugriff (PDF)

Adjuvant chemotherapy with carboplatin and taxane compared with single drug carboplatin in early stage epithelial ovarian carcinoma

Oncology reports, 2007-11, Vol.18 (5), p.1249-1256

2007

Volltextzugriff (PDF)

Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-II

International journal of oncology, 2005-01, Vol.26 (1), p.177

2005

Volltextzugriff (PDF)

Survival and prognostic factors in early‐stage epithelial ovarian carcinoma treated with taxane‐based adjuvant chemotherapy

International journal of gynecological cancer, 2007-11, Vol.17 (6), p.1231-1237

2007

Volltextzugriff (PDF)

Napsin A as a marker of clear cell ovarian carcinoma

BMC cancer, 2013-11, Vol.13 (1), p.524-524, Article 524

2013

Volltextzugriff (PDF)

Cell Cycle Regulator p27 Mediates Body Mass Index Effects in Ovarian Cancer in FIGO-stages I-II

Cancer genomics & proteomics, 2019-11, Vol.16 (6), p.443-450

2019

Volltextzugriff (PDF)

The apoptosis regulators p53, bax and PUMA: Relationship and impact on outcome in early stage (FIGO I-II) ovarian carcinoma after post-surgical taxane-based treatment

Oncology reports, 2012-03, Vol.27 (3), p.741-747

2012

Volltextzugriff (PDF)

Prognostic impact of body mass index andeffect of overweight and obesity on surgical andadjuvant treatment in early-stage epithelialovarian cancer

International journal of gynecological cancer, 2008, Vol.18 (2), p.345

2008

Volltextzugriff (PDF)

A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging

International journal of gynecological cancer, 2004-03, Vol.14 (2), p.259-270

2004

Volltextzugriff (PDF)

Prognostic impact of body mass index and effect of overweight and obesity on surgical and adjuvant treatment in early‐stage epithelial ovarian cancer

International journal of gynecological cancer, 2008-03, Vol.18 (2), p.345-351

2008

Volltextzugriff (PDF)

Prognostic factors in early stages (FIGO I–II) of epithelial ovarian carcinoma

Skirnisdottir, Ingiridur Anna

2002

Volltextzugriff (PDF)

Cell Cycle Regulator p27 Mediates Body Mass IndexEffects in Ovarian Cancer in FIGO-stages I-II

Cancer genomics & proteomics, 2019, Vol.16 (6), p.443

2019

Volltextzugriff (PDF)

Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990–2003: Occurrence, origin and survival compared to ovarian cancer

Gynecologic oncology, 2007-04, Vol.105 (1), p.166-171

2007

Volltextzugriff (PDF)

Is adjuvant radiotherapy in early stages (FIGO I-II) of epithelial ovarian cancer a treatment of the past?

Oncology reports, 2005-08, Vol.14 (2), p.521

2005

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(28)
Dissertationen
(2)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I-II

Prognostic Impact of p53, p27, and C-MYC on Clinicopathological Features and Outcome in Early-Stage (FIGO I-II) Epithelial Ovarian Cancer

Borderline ovarian tumors in Sweden 1960–2005: Trends in incidence and age at diagnosis compared to ovarian cancer

Prognostic Impact of Concomitant p53 and PTEN on Outcome in Early Stage (FIGO I-II) Epithelial Ovarian Cancer

Prognostic factors for surgical outcome and survival in 447 women treated for advanced (FIGO-stages III-IV) epithelial ovarian carcinoma

Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease

The clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancer

Prognostic Factors for Cervical Cancer in FIGO-Stages IA-IIB in a 10-Year Period in the Region of Uppsala, Sweden: Population Cohort Study

Clinical significance of growth factor receptor EGFR and angiogenesis regulator VEGF‑R2 in patients with ovarian cancer at FIGO stages I-II

Differences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma

Body mass index as a prognostic factor in epithelial ovarian cancer and correlation with clinico-pathological factors

Association of p21, p21 p27 and p21 p53 status to histological subtypes and prognosis in low-stage epithelial ovarian cancer

Adjuvant chemotherapy with carboplatin and taxane compared with single drug carboplatin in early stage epithelial ovarian carcinoma

Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-II

Survival and prognostic factors in early‐stage epithelial ovarian carcinoma treated with taxane‐based adjuvant chemotherapy

Napsin A as a marker of clear cell ovarian carcinoma

Cell Cycle Regulator p27 Mediates Body Mass Index Effects in Ovarian Cancer in FIGO-stages I-II

The apoptosis regulators p53, bax and PUMA: Relationship and impact on outcome in early stage (FIGO I-II) ovarian carcinoma after post-surgical taxane-based treatment

Prognostic impact of body mass index andeffect of overweight and obesity on surgical andadjuvant treatment in early-stage epithelialovarian cancer

A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging

Prognostic impact of body mass index and effect of overweight and obesity on surgical and adjuvant treatment in early‐stage epithelial ovarian cancer

Prognostic factors in early stages (FIGO I–II) of epithelial ovarian carcinoma

Cell Cycle Regulator p27 Mediates Body Mass IndexEffects in Ovarian Cancer in FIGO-stages I-II

Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990–2003: Occurrence, origin and survival compared to ovarian cancer

Is adjuvant radiotherapy in early stages (FIGO I-II) of epithelial ovarian cancer a treatment of the past?

Suchergebnisse filtern